Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
42.9M
-
Shares change
-
+2.73M
-
Total reported value, excl. options
-
$593M
-
Value change
-
+$31.9M
-
Put/Call ratio
-
0.1
-
Number of buys
-
71
-
Number of sells
-
-77
-
Price
-
$13.81
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q3 2023
178 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q3 2023.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.9M shares
of 48M outstanding shares and own 89.38% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (7.78M shares), BlackRock Inc. (5.23M shares), VANGUARD GROUP INC (2.54M shares), MILLENNIUM MANAGEMENT LLC (2.53M shares), Park West Asset Management LLC (2.01M shares), FRED ALGER MANAGEMENT, LLC (1.79M shares), GENEVA CAPITAL MANAGEMENT LLC (1.53M shares), PALISADE CAPITAL MANAGEMENT, LP (1.36M shares), STATE STREET CORP (1.18M shares), and Granahan Investment Management, LLC (1.05M shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.